Balaji Amines Ltd

Balaji Amines Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Balaji Amines Ltd

₹ 1,001 -3.29%
13 Mar - close price
balajiamines.com BSE: 530999 NSE: BALAMINES
About

Balaji Amines Ltd specialises in manufacturing Methylamines, Ethylamines, Derivatives of specialty chemicals and Pharma Excipients. These have been the main products, it also have facilities for the manufacturing of derivatives, which are down-stream products for various pharma/pesticide industries apart from user specific requirements. It is one of the largest manufacturers of aliphatic amines in India. [1]

Key Points

Market Leadership
The company is the largest manufacturer of aliphatic amines and their derivatives in India and the sole producer of a few specialty chemicals. [1]

Website BSE NSE
  • Market Cap ₹ 3,248 Cr.
  • Current Price ₹ 1,001
  • High / Low ₹ 1,946 / 905
  • Stock P/E 22.7
  • Book Value ₹ 522
  • Dividend Yield 1.10 %
  • ROCE 13.2 %
  • ROE 9.79 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Company is almost debt free.
  • Company has been maintaining a healthy dividend payout of 19.3%

Cons

  • The company has delivered a poor sales growth of 6.65% over past five years.
  • Company has a low return on equity of 12.7% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals

Part of BSE Allcap BSE Commodities Nifty Microcap 250 Nifty Total Market Nifty500 LargeMidSmall Equal-Cap Weighted

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
413 347 337 325 308 367 333 320 299 322 319 309 301
357 292 286 277 250 278 274 262 248 264 263 259 246
Operating Profit 56 55 52 48 58 89 59 58 52 58 56 50 55
OPM % 14% 16% 15% 15% 19% 24% 18% 18% 17% 18% 18% 16% 18%
2 4 4 5 6 6 5 6 5 6 7 7 5
Interest 1 0 0 1 1 1 0 1 0 0 0 0 0
Depreciation 9 8 8 8 8 9 9 9 10 10 11 12 12
Profit before tax 49 51 47 44 56 85 55 54 47 53 52 45 48
Tax % 26% 26% 27% 26% 25% 26% 26% 26% 24% 25% 24% 30% 32%
36 38 34 33 42 63 41 40 36 40 40 31 32
EPS in Rs 11.24 11.64 10.64 10.09 12.82 19.32 12.51 12.47 11.02 12.22 12.28 9.71 10.01
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
608 602 632 665 858 947 918 1,227 1,914 1,720 1,330 1,266 1,251
517 500 503 513 676 753 738 901 1,473 1,391 1,083 1,040 1,032
Operating Profit 91 102 129 151 182 193 180 327 441 330 247 226 219
OPM % 15% 17% 20% 23% 21% 20% 20% 27% 23% 19% 19% 18% 18%
3 3 2 9 12 5 10 12 18 10 21 23 25
Interest 32 31 20 12 9 13 12 5 7 3 2 2 2
Depreciation 16 19 18 18 19 20 24 23 29 31 34 38 45
Profit before tax 46 56 93 130 166 166 154 310 423 305 232 209 198
Tax % 27% 35% 34% 34% 32% 29% 26% 25% 27% 25% 26% 25%
34 36 61 86 113 118 114 232 308 228 171 156 143
EPS in Rs 10.35 11.22 18.91 26.41 34.93 36.44 35.11 71.51 95.04 70.23 52.87 48.21 44.22
Dividend Payout % 10% 11% 11% 8% 7% 8% 9% 6% 6% 14% 21% 23%
Compounded Sales Growth
10 Years: 8%
5 Years: 7%
3 Years: -13%
TTM: -5%
Compounded Profit Growth
10 Years: 16%
5 Years: 7%
3 Years: -20%
TTM: -20%
Stock Price CAGR
10 Years: 22%
5 Years: -10%
3 Years: -21%
1 Year: -17%
Return on Equity
10 Years: 19%
5 Years: 18%
3 Years: 13%
Last Year: 10%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 6 6 6 6 6 6 6 6 6 6 6 6 6
Reserves 196 231 285 371 461 569 661 891 1,186 1,394 1,528 1,649 1,684
262 236 159 103 115 95 102 0 0 0 0 0 0
158 129 156 175 237 327 334 394 292 151 202 195 177
Total Liabilities 621 603 607 655 819 997 1,104 1,292 1,484 1,551 1,736 1,850 1,868
325 321 322 309 316 318 363 344 495 604 724 833 893
CWIP 8 3 16 25 66 63 46 173 141 74 143 154 137
Investments 21 30 30 30 66 66 114 66 66 128 66 66 66
268 249 238 292 371 550 581 708 782 745 803 797 772
Total Assets 621 603 607 655 819 997 1,104 1,292 1,484 1,551 1,736 1,850 1,868

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
111 60 84 72 126 89 148 94 176 187 217 224
-50 -14 -30 -23 -93 -47 -130 -87 -142 -155 -190 -179
-53 -49 -52 -54 -29 -29 -31 3 -20 -22 -35 -38
Net Cash Flow 7 -3 2 -5 4 13 -13 10 14 10 -8 8

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 79 70 69 67 73 64 76 81 83 55 72 71
Inventory Days 87 93 62 88 70 100 66 56 69 97 127 129
Days Payable 83 46 57 55 56 58 40 43 57 13 35 34
Cash Conversion Cycle 83 117 74 100 87 106 102 94 95 139 164 166
Working Capital Days -17 2 6 31 29 46 46 80 80 98 118 117
ROCE % 18% 19% 24% 30% 33% 29% 23% 38% 41% 24% 16% 13%

Insights

In beta
Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Aliphatic Amines Sales Volume
MT

Log in to view insights

Please log in to see hidden values.

Login
Amine Derivatives Sales Volume
MT
Consolidated Sales Volume
MT
Specialty Chemicals Sales Volume
MT
N-Butylamine Capacity Utilization
%
Total Installed Capacity
TPA

Shareholding Pattern

Numbers in percentages

32 Recently
Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
53.71% 53.71% 53.71% 53.71% 53.71% 53.71% 53.71% 53.71% 54.62% 54.59% 54.59% 54.59%
4.45% 4.55% 4.52% 4.58% 4.92% 5.05% 5.27% 5.16% 5.09% 5.00% 4.53% 3.30%
0.34% 0.18% 0.90% 1.43% 1.48% 1.59% 1.79% 1.66% 1.48% 1.46% 1.52% 1.53%
41.50% 41.57% 40.88% 40.31% 39.91% 39.67% 39.23% 39.46% 38.83% 38.96% 39.37% 40.59%
No. of Shareholders 1,36,6441,40,9571,44,9901,41,4171,38,0171,32,4281,29,1601,29,3611,27,4421,21,9501,18,8941,17,591

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls